Gene therapy in autoimmune diseases

Annals of the Rheumatic Diseases

Volumn 57, Issue 3, 1998, Pages 125-127

  Evans, C H ^a   Whalen, J D ^b   Ghivizzani, S C ^c   Robbins, P D ^a  

^a Department of Orthopaedic Surgery ^*  (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

AUTOIMMUNE DISEASE; GENE EXPRESSION; GENE THERAPY; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT INDICATION;

EID: 0031802507     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.3.125     Document Type: Short Survey

References (25)

1. Evans CH, Robbins PD. Prospects for treating autoimmune and inflammatory diseases by gene therapy. Gene Ther 1996;3:187-9.
2. Robbins PD, ed. Gene therapy potocols. Totowa, NJ: Human Press, 1996.
3. Lau HT, Yu M, Fontana A, Stoeckert CJ. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996;270:109-I2.
4. Parker DC, Greiner DL, Phillips NE, Appel MC, Steele A\V, Durie FH, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogenic small lymphocytes and antibody to CD40 ligand. Proc Nail Acad Sei USA 1995;92:560-4.
5. Finck BK, Linsley PS, VTofsy D. Treatment of murine lupus with CTLA41g. Science 1994;265:1225-7.
6. Mosmann TR, Coffman RL. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-73.
7. DeVTaal-Malefyl R, Abrams J, Bennett B, Fidgor CG, DeVries JF. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocjtes. J Exp Med 1991;174:1209-20.
8. Moreland L\X', Heck L\V, Koopman \VJ . Biologic agents for treating rheumatoid arthritis. Concepts and progress. Arthritis Rheum 1997;40:397409.
9. Makarov SS, Baldwin AS. Local suppression of NF-kB inhibits experimental arthritis in rats. Arthritis Rheum 1996;39 (suppl):S121.
10. Shiozawa S, Shimizu K, Tanaka K, Hiro K. Studies on the contribution of c-fos/AP-1 to arthritic joint destruction. J Clin Invest 1997;99:1210-16.
11. Raz E, Watanabe A, Baird SM, Eisenberg RA, Parr TG, Lotz M, et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Nad Acad Sei USA 1993;90:4523-7.
12. Raz E, Dudler J, Lotz M, Baird SM, Berry CC, Eisenberg RA, et al. Modualtion of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 1995;4:286-92.
13. Giladi E, Raz E, Karmeli F, Okon E, Rachmilewitz D. Transforming growth factor-beta gene therapy ameliorates experimental colitis in rats. Eur J Gastroenterol Hepatol 1995;7:341-7.
14. Kang R, Ghivizzani SC, Herndon JH, Robbins PD, Evans CH. Gene therapy for arthritis: principles and clinical practice. Biochem Soc Trans 1997;25:533-7.
15. Evans CH, Robbins PD. Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheumatol 1996;8:230-4.
16. Otani K, Nita I, Macaulay W, Georgescu HI, Robbins PD, Evans CH. Suppression of antigen-induced arthritis by gene therapy. J Immunol 1996;156:3558-62.
17. Makarov SS, Olsen JC, Johnston \VN, Anderle SK, Brown RR, Baldwin AS, et a!. Suppression of experimental arthritis by gene transfer of interleukin-1 receptor antagonist cDNA. Proc Nad Acad Sei USA 1996;93:402-6.
18. Bakker AC, Joosten LAB, Arntz OJ, Helsen AIMA, Bendele AM, Van De Loo FAJ, et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheuml997;40:893-900.
19. Ghivizzani S, Kang R, Hatton C, Tio C, Lechman E, Emmert A, et al. In vivo delivery of genes encoding soluble receptors for IL-1 and TNF-a results in a synergistic therapeutic effect in antigen-induced arthritis in the rabbit knee. Arthritis Rheum 1996;39 (suppl):S308.
20. Chernajovsky Y, Adama G, Podhajcer O, Müller G, Robbins PD, Felmann M. Inhibition of transfer of collagen induced arthritis into SCID mice by gene transfer of spleen cells with retroviruses expressing soluble human tumor necrosis factor receptor. Gene Ther 1995;2:731-5.
21. Shaw MK, Lorens JB, Dhawan A, DalCanto R, Tse HY, Tran AB, et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 1997;185:1711-14.
22. Boggs SS, Patrene KD, Mueller GM, Evans CH, Doughty LA, Robbins PD. Prolonged systemic expression of human IL-1 receptor antagonist (hlL-lra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hlL-lra cDNA. Gene Ther 1995;2:632-8.
23. Doughty LA, Patrene KD, Evans CH, Boggs SS, Robbins PD. Constitutive systemic expression of IL-IRa or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10. Gene Ther 1997;4:252-7.
24. McCarthy M. Gene therapy for rheumatoid arthritis starts clinical trials. Lancet 1996;348:323.
25. Evans CH, Robbins PD, Ghivizzani SD, Herndon JH, Kang R, Bahnson AB, et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996;7:1261-80.